Adagene, Inc. (ADAG)
3.56
-0.22
(-5.82%)
USD |
NASDAQ |
Jun 02, 12:03
Adagene Enterprise Value : 265.44M for June 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ascletis Pharma, Inc. | 1.670B |
| CStone Pharmaceuticals Co. Ltd. | 883.84M |
| RemeGen Co., Ltd. | 6.696B |
| InnoCare Pharma Ltd. | 1.970B |
| JW (Cayman) Therapeutics Co. Ltd. | -- |
Enterprise Value Related Metrics
| Earnings Yield | -10.51% |
| Normalized Earnings Yield | -10.53 |